Potential role of matrix metalloproteinase-8 as a predictive marker for peri-implant mucositis progress
Main Article Content
Abstract
Background: Osseointegrated dental implants have become increasingly common as a treatment option for missing teeth. Peri-implant infections are caused by bacterial plaque that may initiate an inflammatory release of cytokines, enhance accumulation of neutrophils in implant lesion, and trigger the production of matrix metalloproteinase-8 (MMP-8). MMP-8 is essential in inflammatory and degenerative processes of periodontal tissues and produced by activated cells. The purpose of this study was to detect the role of MMP-8 as a biomarker of active and aggressive peri-implant mucositis. Material and method: Eighty subjects (40 with peri-implant mucositis and 40 with successful and healthy peri-implant mucosa) were enrolled in this study. The 42 male and 38 female subjects were attended at AL-Karama and AL-Ma'amoun Specialized Dental Centers in Baghdad, Iraq from November 24, 2021 to May 25, 2022. Follow-up examinations were performed on patients to monitor the progression of disease. Peri-implant sulcular fluid was examined and identified using enzyme-linked immunosorbent assay technique for MMP-8. Results: Results showed that MMP-8 levels continue to rise after 3 weeks and are significantly higher in the patient group (P=0.00000) than the group with successful implants. Conclusion: MMP-8 can be used to reflect, associate, and predict clinical disease activity and progression of peri-implant mucositis properly.
Received date: 10-07-2022
Accepted date: 30-09-2022
Published date: 15-06-2025
Downloads
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licenses and Copyright
The following policy applies in The Journal of Baghdad College of Dentistry (JBCD):
# JBCD applies the Creative Commons Attribution (CC BY) license to articles and other works we publish. If you submit your paper for publication by JBCD, you agree to have the CC BY license applied to your work. Under this Open Access license, you as the author agree that anyone can reuse your article in whole or part for any purpose, for free, even for commercial purposes. Anyone may copy, distribute, or reuse the content as long as the author and original source are properly cited. This facilitates freedom in re-use and also ensures that JBCD content can be mined without barriers for the needs of research.
# If your manuscript contains content such as photos, images, figures, tables, audio files, videos, etc., that you or your co-authors do not own, we will require you to provide us with proof that the owner of that content (a) has given you written permission to use it, and (b) has approved of the CC BY license being applied to their content. We provide a form you can use to ask for and obtain permission from the owner. If you do not have owner permission, we will ask you to remove that content and/or replace it with other content that you own or have such permission to use.Don't assume that you can use any content you find on the Internet, or that the content is fair game just because it isn't clear who the owner is or what license applies.
# Many authors assume that if they previously published a paper through another publisher, they own the rights to that content and they can freely use that content in their paper, but that’s not necessarily the case, it depends on the license that covers the other paper. Some publishers allow free and unrestricted re-use of article content they own, such as under the CC BY license. Other publishers use licenses that allow re-use only if the same license is applied by the person or publisher re-using the content. If the paper was published under a CC BY license or another license that allows free and unrestricted use, you may use the content in your JBCD paper provided that you give proper attribution, as explained above.If the content was published under a more restrictive license, you must ascertain what rights you have under that license. At a minimum, review the license to make sure you can use the content. Contact that JBCD if you have any questions about the license. If the license does not permit you to use the content in a paper that will be covered by an unrestricted license, you must obtain written permission from the publisher to use the content in your JBCD paper. Please do not include any content in your JBCD paper which you do not have rights to use, and always give proper attribution.
# If any relevant accompanying data is submitted to repositories with stated licensing policies, the policies should not be more restrictive than CC BY.
# JBCD reserves the right to remove any photos, captures, images, figures, tables, illustrations, audio and video files, and the like, from any paper, whether before or after publication, if we have reason to believe that the content was included in your paper without permission from the owner of the content.
How to Cite
References
Padhye N, Bhange P, Mehta L, Khimani S. Patient awareness and perceived cost of dental implants for replacement of missing teeth: A survey in an Indian metropolitan population. J Dent Implants. 2019;9(1):30.
Türkoğlu O. Peri-Implant Diseases: Peri-implant Mucositis And Peri-implantitis. J Ege Uni School Dent. 2017;38(1):21–31.
Qadadha YM, Gauthier GM, Hartig GK. Progressive Inflammatory Process of the Mandible and Surrounding Soft Tissues. JAMA Otolaryngol Head Neck Surg. 2022;148(2):193–194.
Lee CT, Huang YW, Zhu L, Weltman R. Prevalences of periimplantitis and peri-implant mucositis: systematic review and meta-analysis. J Dent. 2017 Jul; 62:1–12.
Durrani, F, Pandey S, Nahid R., Singh P, Pandey A. Thick soft tissues around implant-supported restoration; stable crestal bone levels? J Denl Implants. 2021;11(2):109.
Renvert S, Persson, G.R, Pirih FQ, Camargo, PM. Peri-implant health, peri-implant mucositis, and peri-implantitis: Case definitions and diagnostic. J Perio. 2018 Jun;89:S304-12.
Meyer S, Giannopoulou C, Courvoisier D, Schimmel M, Müller F, Mombelli A. Experimental mucositis and experimental gingivitis in persons aged 70 or over. Clinical and biological responses. Clini oral implants Res. 2016 Jun 23;28(8): 1005-1012.
Pérez-Chaparro PJ, Gonçalves C, Figueiredo LC, Faveri M, Lobão E, Tamashiro N, et al. Newly identified pathogens associated with periodontitis: a systematic review. J Dent Res.. 2014 Sep;93(9):846-58.
Wang, X. Inhibition of HtrA2 alleviates inflammatory response and cell apoptosis in lipopolysaccharide induced acute pneumonia in rats. Mol Med Rep. 2020 Aug 4: 3127-3134.
Khuda F, Najmi Mohamad Anuar N, Baharin B, Shaqinah Nasruddin N. A mini review on the associations of matrix metalloproteinases (MMPs) -1, -8, -13 with periodontal disease. J AIMS Mol Sci. 2021; 8(1): 13-31.
Mor, A, Ben-Moshe, O, Mekori, Y.A, Kloog, Y. Inhibitory Effect of Farnesylthiosalicylic Acid on Mediators Release by Mast Cells: Preferential Inhibition of Prostaglandin D2 and Tumor Necrosis Factor-α Release. J Inflam. 2010 Aug 13;34(5): 314–318.
Kasim ZM, Younis WH. Immunohistochemical expression of MMP1 and TIMP1 as markers of migration in Hodgkin’s and non-Hodgkin’s lymphoma of the head and neck region (A comparative study) . J Bagh Coll Dent. 2014;26(3):72-8.
Sercu S, Zhang M, Oyama N, Hansen U, Ghalbzouri AE, Jun G, et al. Interaction of extracellular matrix protein 1 with extracellular matrix components: ECM1 is a basement membrane protein of the Skin. J Invest Derm. 2008 Jun 1;128(6):1397-408.
Bazarova NS, Kh ZS. The Role Of Polymorphic Genes Of Matrix Metalloproteinases (MMPS) And Their Tissue Inhibitors In The Development Of Renal Dysfunction In Chronic Glomerulonephritis In Children. Americ J Med Sci and Pharma Res 2021 Jun 30;3(06):195-202.
Sapna G, Gokul S, Bagri-Manjrekar K. Matrix metalloproteinases and periodontal diseases. Oral Dis. 2013 Jul 15;20(6):538–550.
Atarchi AR. Potential of Salivary Matrix Metalloproteinase 9 to Discriminate Periodontal health and disease. J BaghColl Dent. 2022;34(2):74-9. DOI:
Luchian I, Goriuc A, Sandu D, Covasa M. The role of matrix metalloproteinases (MMP-8, MMP-9, MMP-13) in periodontal and peri-implant pathological processes. Int J mol sci. 2022 Feb 4;23(3):1806.
Salminen A, Gursoy UK, Paju S, Hyvärinen K, Mäntylä P, Buhlin K, et al. Salivary biomarkers of bacterial burden, inflammatory response, and tissue destruction in periodontitis. J Clin Perio. 2014 May;41(5):442-50.
Thierbach R. Peri-Implant Sulcus Fluid (PISF) Matrix Metalloproteinase (MMP) -8 Levels in Peri-Implantitis. J Clin Diag Res.2016: ZC34-8.
Chaushu L, Shabat R, Gadyukov A, Chaush G. A two-piece dental implant comprising a replaceable thin titanium sleeve may be a new approach to re-osseointegration following peri-implant disease. Med Hypo. 2018;121:103–105.
Dursun E, Tözüm TF. Peri-implant crevicular fluid analysis, enzymes and biomarkers: a systemetic review. J Oral Max Res. 2016 Sep 9;7(3):e9.
Uzunkaya M , Gundogar H. Evaluation of periostin levels in gingival crevicular fluid and peri-implant sulcus fluid in patients with periodontal and peri-implanter disease: A cross-sectional study. Annals Med Res. 2019;26(10):2093.
Sham M, Aboukhadr M, Madi M, Abdelhady S. Comparison between level of intereukin 10 in the gingival crevicular fluid and peri-implant sulcular fluid around healthy dental implants (split mouth study). Alex Dent J. 2016;41(1): 26–30.
Cakal TO, Efeoglu C, Bozkurt E. The evaluation of peri-implant sulcus fluid osteocalcin, osteopontin, and osteonectin levels in peri-implant diseases. J Periodontol. 2018;89:418–423.
Salvi GE, Aglietta M, Eick S, Sculean A, Lang NP, Ramseier CA. Reversibility of experimental peri-implant mucositis compared with experimental gingivitis in humans. Clin Oral Implants Res. 2012;23:182-190.
Bhardwaj S, Prabhuji ML. Comparative volumetric and clinical evaluation of peri-implant sulcular fluid and gingival crevicular fluid. J Periodont Implant Sci. 2013; 43:233-42.
Kamal MN. Implant Satbility and Peri-implant Marginal Bone Loss Around Two Different Threads Design Implants. Egy Dent J. 2020 Oct 1;66(4-October (Fixed Prosthodontics, Removable Prosthodontics and Dental Materials)):2607-19.
Koller GM, Schafer C, Kemp SS, Aguera KN, Lin PK, Forgy JC, et al. Proinflammatory Mediators, IL (Interleukin)-1β, TNF (Tumor Necrosis Factor) α, and Thrombin Directly Induce Capillary Tube Regression. ATVB. 2020;40(2):365–377.
Mauramo M, Ramseier AM, Mauramo E, Buser A, Tervahartiala T, Sorsa T, et al. Associations of oral fluid MMP‐8 with periodontitis in Swiss adult subjects. Oral Dis. 2018 Apr;24(3):449-55.
Kivelä‐Rajamäki MJ, Teronen OP, Maisi P, Husa V, Tervahartiala TI, Pirilä EM, et al. Laminin‐5 γ2‐chain and collagenase‐2 (MMP‐8) in human peri‐implant sulcular fluid. Clin Oral Implants Res. 2003 Apr;14(2):158-65.
Xu L, Yu Z, Lee HM, Wolff MS, Golub LM, Sorsa T, et al. Characteristics of collagenase-2 from gingival crevicular fluid and peri-implant sulcular fluid in periodontitis and peri-implantitis patients: pilot study. Acta Odonto Scandina. 2008 Jan 1;66(4):219-24.
Ramseier CA, Eick S, Brönnimann C, Buser D, Brägger U, Salvi G.E. Host-derived biomarkers at teeth and implants in partially edentulous patients. A 10-year retrospective study. Clin Oral Implants Res. 2015 Feb 16,:27(2):211–217.
Ziebolz D, Schmalz G, Gollasch D, Eickholz P, Rinke S, Microbiological and aMMP-8 findings depending on periimplant disease in patients undergoing supportive implant therapy. Diag Micro Infec Dise. 2017 May 1;88(1):47–52.
Alassiri S, Parnanen P, Rathnayake N, Johannsen G, Heikkinen AM, Lazzara R, et al. The ability of quantitative, specific, and sensitive point‐of‐care/chair‐side oral fluid immunotests for aMMP‐8 to detect periodontal and peri‐implant diseases. Dis Mark. 2018;2018(1):1306396.
Aleksandrowicz P, Żelechowska P, Agier J, Starska K, Kędzierski K, Wysokińska-Miszczuk J, et al. Evaluation of metalloproteinase‐8 levels in crevicular fluid of patients with healthy implants or periodontitis. Med Inflamm. 2017;2017(1):4920847.
Arakawa H, Uehara J, Hara ES, Sonoyama W, Kimura A, Kanyama M, et al. Matrix metalloproteinase-8 is the major potential collagenase in active peri-implantitis. J Pros Res. 2012;56(4):249-55.
Luchian I, Goriuc A, Sandu D, Covasa M. The Role of Matrix Metalloproteinases (MMP-8, MMP-9, MMP-13) in Periodontal and Peri-Implant Pathological Processes. Int J Mol Sci. 2022;23(3):1806.
Yakob M, Kari K, Tervahartiala T, Sorsa T, Söder PÖ, Meurman JH, et al. Associations of Periodontal Microorganisms with Salivary Proteins and MMP-8 in Gingival Crevicular Fluid. J. Clin. Periodontol. 2012; 39: 256–263.